Millennium Dental Technologies, Inc. Receives United States Patent for LANAP® Protocol
The LANAP® protocol for the treatment of periodontitis is officially protected by the United States Patent and Trademark Office
CERRITOS, Calif.-- Millennium Dental Technologies, Inc. announced U.S. Patent No. 9,943,379 has been issued for the LANAP® protocol. This minimally-invasive surgical treatment for periodontitis is performed using the PerioLase® MVP-7™, the only dental laser specifically designed and configured to support the LANAP® protocol.
"At Millennium Dental, our guiding vision is 'it's all about the patient.' This patent protects patients by clearly illustrating that the LANAP® protocol is a specific surgical procedure requiring in-depth training. Clinicians performing the LANAP® protocol must complete the proper training to maximize patient safety and clinical results before they are extended a license to perform the protocol," states Robert H. Gregg II, DDS, inventor of the LANAP® protocol and Founder and President of Millennium Dental Technologies, Inc. "Patients should request to see the LANAP® license of any clinician claiming to perform the LANAP® protocol before accepting any treatment, and ensure the doctor uses the PerioLase MVP-7 dental laser. No other laser meets the specifications required for the LANAP® protocol."
In March 2016, the LANAP® protocol was awarded the world's first FDA clearance for True Periodontal Regeneration—regenerating alveolar bone, periodontal ligaments and cementum on a previously diseased root surface. This groundbreaking clearance remains the only FDA clearance for full mouth True Periodontal Regeneration that is evidence-based and scientifically validated with human histology. The PerioLase MVP-7 is the only FDA cleared device for True Regeneration with the LANAP® protocol.
While part of the standard of care, the LANAP® protocol is unique within the field of periodontal treatment, and has increasingly become the preferred option due to predictable successful results and positive patient experience.